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Abstract
PCD in protozoan parasites has emerged as a fascinating field of parasite biology. This not only relates to the
underlying mechanisms and their evolutionary implications but also to the impact on the parasite-host interactions
within mammalian hosts and arthropod vectors. During recent years, common functions of apoptosis and autop-
hagy in protozoa and during parasitic infections have emerged. Here, we review how distinct cell death pathways
in Trypanosoma, Leishmania, Plasmodium or Toxoplasma may contribute to regulation of parasite cell densities in
vectors and mammalian hosts, to differentiation of parasites, to stress responses, and to modulation of the host
immunity. The examples provided indicate crucial roles of PCD in parasite biology. The existence of PCD pathways
in these organisms and the identification as being critical for parasite biology and parasite-host interactions could
serve as a basis for developing new anti-parasitic drugs that take advantage of these pathways.
Introduction
Surprisingly, the question of how protozoan parasites
die was neglected for a long time. Death of unicellular
organisms was generally assumed to occur in an unco-
ordinated manner, and the processes involved in life-or-
death decisions after treatment of parasites with che-
motherapeutic agents or after induction of anti-parasitic
immunity were therefore largely ignored. This was
mostly due to the assumption that genetically deter-
mined death pathways in single-celled organisms are not
favourable during evolution. With the detection, how-
ever, of cell death markers characteristic for metazoan
programmed cell death (PCD) in diverse free-living and
parasitic protozoa their pathways to death became a
topic of intense research.
Three main cell death pathways, i.e. apoptosis, autop-
hagic cell death and necrosis are now being generally
considered [1] and it has been recently proposed to
adopt the criteria of this classification also for PCD in
protozoa [2]. Signs of apoptosis have been recognized in
divergent unicellular parasites including kinetoplastids,
apicomplexans, Trichomonas vaginalis, Giardia lamblia
and Blastocystis hominis [3]. Markers for apoptosis in
protozoan parasites include cell shrinkage, chromatin
condensation, DNA and nuclear fragmentation, loss of
mitochondrial membrane potential (MMP) and translo-
cation of phosphatidylserine (PS) from the inner to the
outer leaflet of the plasma membrane, while the plasma
membrane is not disrupted at least during early stages
[4]. In contrast, necrosis typically includes cell and orga-
nelle swelling, loss of plasma membrane integrity and
only moderate chromatin condensation. Death by necro-
sis has been described in trypanosomes [5,6]. It has also
been suggested for blood stages of Plasmodium [7]
although this is still a matter of debate [8,9]. It is impor-
tant to note that necrosis can occur in a regulated and
physiological manner [10,11] and that it is nowadays at
least not generally considered an uncontrolled form of
death. Autophagy is an evolutionary conserved process
which is presumably present in all protozoan parasites
[12]. It is thought to function primarily as a survival
mechanism which is used to provide the cell with
energy during stress conditions including starvation, for
organelle turnover, or for remodelling a cell during dif-
ferentiation. However, when adverse conditions take too
long and exceed cellular capacity, they could promote
autophagic cell death [13]. Autophagic cell death is thus
defined as cell death that occurs in the context of
autophagy [1] and has been described in several proto-
zoan parasites [14-19]. The most important step in
autophagy is the formation of a new membrane to
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engulf cellular material (cargo) to be digested; this mem-
brane that eventually forms a double membrane-sur-
rounded vesicle is called the autophagosome.
One of the main questions that emerge from the
detection of PCD pathways in protozoan parasites is
how we can exploit these processes to combat some of
the most widespread and deadly infectious agents of
humans and animals more efficiently. Surely, detailed
knowledge of the death-inducing signals and environ-
mental conditions, the underlying transduction path-
ways, and the death effectors of protozoan parasites are
not only of major scientific interest but will open a
treasure chest for the development of new anti-parasitic
therapies. Another major prerequisite for exploiting pro-
tozoan PCD pathways is however a clear picture about
the physiological implications of parasite PCD on the
host-pathogen interaction and the course of disease.
During recent years, several common themes emerged
on the physiological functions of cell death pathways in
protozoa. In the following, we discuss current knowl-
edge on how parasite PCD might regulate parasite den-
sities within the host, how it is involved in stress
responses and differentiation of protozoan parasites, and
how it modulates host immunity to infection. Where
applicable, the molecular mechanisms which govern
these processes are also reviewed.
Regulation of parasite cell density by protozoan cell
death
In order to establish sustained infections and transmis-
sion to new hosts, most parasites must avoid hyper-
parasitism which would lead to the death of both the
host and the parasite. Parasite numbers can be regulated
by cell proliferation, cell cycle progression, or cell death.
PCD in distinct protozoan parasites appears to deter-
mine cell densities at least under certain conditions
(Table 1) and we hypothesize that it critically affects the
parasite-host interaction by facilitating a sustained para-
site-host equilibrium.
Apoptosis and cell density of African trypanosomes
Trypanosoma brucei, i.e. the causative agent of sleeping
sickness in humans and of nagana in cattle can undergo
apoptosis in the mammalian bloodstream form (BSF)
[20,21] and the procyclic form within the midgut of the
tsetse fly [22,23]. In the mammalian bloodstream, para-
sitemia of T. brucei increases and decreases periodically
and this is partially due to effective antibody-mediated
immune responses of the host and antigenic variation of
the major surface glycoprotein of the parasite. However,
the cell density of T. brucei is also regulated in axenic
cultures in the absence of any host-derived immune
effectors. After reaching a cell density-dependent thresh-
old, further expansion of the cell population is restricted
by differentiation from the replicating long slender (LS)
form to the non-dividing short stumpy (SS) form [24].
Subsequently, the parasite density even decreases and
this is accompanied by the occurrence of morphological
and biochemical markers for apoptosis [20]. Likewise,
cultivation of T. brucei rhodesiense under high-density
conditions correlates with the appearance of parasites
displaying an apoptotic phenotype [21]. Interestingly,
Figarella and colleagues showed that cell death in BSF
trypanosomes can also be induced in vitro by prosta-
glandin (PG) D2 and its metabolites of the J series in a
dose-dependent manner, but not by PGE2 or PGF2
[20,25]. The IC50 of PGD2, i.e. the concentration neces-
sary to inhibit cell growth of T. brucei BSF by 50% is 3.7
μM and this corresponds to the occurrence of 50%
TUNEL-positive parasites after treatment with 5 μM
PGD2 [20]. Trypanosomes produce PGs including PGD2
and secrete them into the environment [26]. In addition,
levels of PGs increase in plasma and cerebrospinal fluid
during human infections with T. brucei although it
remains unknown whether these are mainly derived
from the host or the parasite [27]. It is thus tempting to
speculate that African trypanosomes sense the total level
of both parasite-derived and host-derived PGD2 and its
metabolites in their environment initiating a cell death
program that subsequently leads to a reduction in para-
site density. Such self-restriction would be probably par-
ticularly relevant during late-stage trypanosomiasis when
parasites have invaded the central nervous system (CNS)
and where PG levels are particularly elevated [27]. In
addition, the immune defence against T. brucei is lim-
ited within the CNS and may therefore not suffice to
restrict parasite numbers efficiently enough to favour a
sustained infection. However, it might well be that PG-
induced apoptosis also contributes to the restriction in
parasite numbers in the peripheral blood.
After uptake of SS forms with the blood meal and dif-
ferentiation to procyclic insect stages, the parasite load
within the tsetse midgut remains remarkably constant
despite their ability to divide [23]. This density regula-
tion might be accomplished by apoptotic cell death as
observed after treatment of procyclic T. brucei rhode-
siense in vitro with the lectin concanavalin A [22,28].
Most trypanosomes of an infective blood meal indeed
die within the midgut via a death process that display
features of apoptosis and are consequently unable to
establish within the midgut [29]. It was thus hypothe-
sized that apoptotic cell death can regulate densities of
procyclic trypanosomes in the tsetse midgut [23,30]. A
correlation between parasite density and the level of
apoptosis has however not been established yet. An
important question also remains whether apoptosis in
procyclic trypanosomes has evolved as a mechanism of
parasite-initiated self-regulation or rather represents a
pathway to death that is induced by immune factors of
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the insect vector. The latter view is supported by find-
ings that parasite apoptosis appears to be regulated by
lectins and possibly also antimicrobial peptides present
in the midgut of tsetse flies [31,32]. Furthermore, anti-
oxidants within the blood meal protect procyclic trypa-
nosomes from undergoing apoptosis indicating that
reactive oxygen species (ROS) may also play a major
role [33]. Whether such inhibition of parasite cell death
leads to hyperparasitism and vector killing has, however,
not been elucidated. Together, these data show that
apoptosis of procyclic trypanosomes in the midgut of its
vector may contribute to the parasite density in this
compartment but it is unknown whether this PCD is a
form of self-restriction in order to facilitate transmission
to new hosts or is rather a form to die after immune
attack.
Plasmodium densities in the insect vector
Ookinetes of the rodent malaria species Plasmodium
berghei can show several typical features of apoptotic
cells both in vivo within the midgut of female anophe-
line mosquitoes and in vitro [34,35]. It should be
stressed that the exact conditions that favour the occur-
rence of apoptotic P. berghei ookinetes in vitro still need
to be unravelled since in another study only very low
levels of ookinetes displaying typical features of apopto-
sis were detected [36]. Signs of apoptosis have recently
also been found in P. yoelli ookinetes in vitro [37], and
work published by Arambage and colleagues suggests
that also P. falciparum, i.e. the etiological agent of
human malaria tropica, can undergo apoptosis in the
insect midgut [35]. Plasmodium ookinetes differentiate
from zygotes after the uptake of macro- and microga-
metocytes with the blood meal from an infective host
and fertilization. Since they subsequently develop within
the midgut epithelium into oocysts with up to thou-
sands of sporozoites, survival of ookinetes critically
determines the parasitic load of the malaria vector.
Importantly, distinct caspase inhibitors inhibit the
occurrence of apoptotic Plasmodium midgut stages in
vitro and in vivo and increase the number of oocysts sig-
nificantly [34]. Caspases take a central role in apoptosis
of higher eukaryotes but homologues are absent in pro-
tozoa [38]. It is, therefore, at first sight surprising that
caspase inhibitors abolish apoptosis in Plasmodium
parasites; however, this could be due to the unspecific
inhibition of non-caspase parasite proteases by the high
inhibitor concentrations used in that study. In common
with other protozoan parasites, Plasmodium spp. express
multiple proteases including cysteine proteases [39] that
might help to disassemble the parasitic cell. In addition,
metacaspases, i.e. related cysteine proteases that share
with caspases the presence of a conserved catalytic dyad
have been described in several protozoa including Plas-
modium falciparum [8,38]. Whether they are indeed
involved in the cell death of protozoa is debated since
they also fulfil PCD-unrelated functions. Recently, clan
CA cysteine proteases which include the cathepsins and
calpains have been implicated in a chloroquine-induced
apoptotic pathway in P. falciparum as determined by
inhibitor studies [40]. While these studies provide valu-
able clues to possible cell death pathways, further func-
tional analyses are clearly needed to prove a putative
Table 1 Programmed cell death pathways and their possible roles in parasite biology and parasite-host interaction
Function Parasite/Stage Host Form of death/Sign. pathway Citations
Density control T. brucei/short stumpy mammal apoptosis [20,21]
T. brucei/procyclic tsetse fly apoptosis [22,23]
P. berghei, P. falciparum/ookinetes vector apoptosis [34,35]
T. cruzi/epimastigotes vector apoptosis [44,47]
T. cruzi/amastigotes mammal apoptosis [45,46]
Immune silencing L. major/promastigotes mammal apoptosis [60,61]
L. amazonensis/amastigotes mammal apoptosis [65]
T. cruzi/trypomastigotes vector, mammal apoptosis [66]
T. brucei/short stumpy mammal apoptosis [70]
Toxoplasma/tachyzoites mammal apoptosis [71]
Differentiation L. major, L. mexicana sand fly, mammal autophagy [75,76]
T. brucei mammal, sand fly autophagy [81]
T. cruzi/epimastigotes vector autophagy [84]
Stress response
starvation T. brucei tsetse fly autophagy [87]
ROS, DHA, neuropeptides T. brucei/blood stream form mammal autophagy/autophagic cell death [15,16,87,90]
chemotherapeutic agents T. cruzi/epimastigotes, trypomastigotes vector, mammal autophagy/cell death [6,17,18,91-93]
starvation T. cruci vector autophagy [84]
heat shock L. infantum, L. donovani, L. amazonensis mammal apoptosis [97-101]
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involvement of these proteases in the execution of pro-
tozoan apoptotic pathways. In should also be stressed
that caspase-independent pathways of apoptosis are pre-
sent in metazoans as well. Whatever the molecules
involved, the results outlined above suggest that apopto-
sis in Plasmodium zygotes and/or ookinetes indeed reg-
ulate the intensity of infection within the Anopheles
vector although alternative explanations as for example,
an indirect effect via the modulation of apoptosis in
insect host cells cannot be completely ruled out. As dis-
cussed for procyclic trypanosomes, it also awaits future
clarification whether apoptosis of Plasmodium midgut
stages has evolved as a form of self-restriction and is
required in order to avoid death of the anopheline vec-
tor before transmission of the parasite to new hosts is
accomplished.
Signs of apoptosis have also been observed in blood
stages of P. falciparum [8,41-43] but this was not con-
firmed by others [7,9]. It thus has to be clarified under
which conditions malaria blood stages exactly can initi-
ate an apoptotic program. Also the hypothesis that such
apoptosis may contribute to regulating the number of
infected red blood cells [42] remains to be supported.
Regulation of T. cruzi densities inside and outside cells?
Markers of apoptosis have been extensively found in T.
cruzi, i.e. the etiological agent of Chagas’ disease, both
in vitro and in vivo [44-47]. Exponential growth of axe-
nic epimastigotes (EPI), i.e. the proliferative stage pre-
sent in the reduviid vector leads to a massive increase of
parasites with an apoptotic phenotype which is asso-
ciated with onset of a stationary growth phase [44,47].
Importantly, the appearance of apoptotic cell death can
be prevented by resuspending exponentially grown para-
sites at decreased densities and this also delays the onset
of the stationary growth phase [44]. This clearly indi-
cates that the appearance of apoptotic T. cruzi EPI
depends on parasite density and may indeed regulate
the size of the population in vitro. However, whether
this also occurs in the reduviid vector and how this
might be regulated is currently unknown.
In T. cruzi-infected cardiomyocytes, a varying propor-
tion of intracellular amastigotes (AMA) can also
undergo apoptosis in vitro and in vivo [45,46]. The regu-
lated death of intracellular parasites is remarkable since
a ‘silent’ removal of the apoptotic cells as described for
mammalian cells or extracellular parasites cannot occur
making the further fate of the dead cell questionable.
Whatever the fate is, the parasite is nevertheless with-
drawn from the pool of replicating AMA and may
hence restrict the further propagation inside the host
cell. This view is supported by findings that in vitro the
numbers of intracellular AMA of two different T. cruzi
strains inversely correlate with the number of TUNEL-
positive parasites [46]. For example, ~50% of TUNEL-
positive AMA of the T. cruzi clone Y (a type II bio-
deme) led to only 4-5 parasites per cardiomyocyte
within two days of intracellular development whereas
~25% TUNEL positivity led to 10-18 parasites of the
Dm28c clone (a type I biodeme) per host cell. This sug-
gests a reduction of the intracellular infection level by
50-75% via an apoptotic cell death and provides a first
hint that the level of T. cruzi AMA cell death might
indeed contribute to the regulation of the intracellular
level of infection [46]. However, one has to stress that
time course analyses of prolongued infections with T.
cruzi clone Y in cardiomyocytes did not corroborate this
hypothesis since after three days of infection a signifi-
cant increase of intracellular parasites was observed
despite continuously high levels of TUNEL-positive
AMA [48]. Thus, whether and under which conditions
apoptosis in T. cruzi determines the level of intracellular
infection awaits future clarification.
In conclusion, several findings including correlations
between parasite densities and the occurrence of apop-
totic parasites, the sensing of population sizes via dis-
tinct environmental cues, and the ability to
experimentally manipulate parasite densities by altering
cell death pathways clearly support the hypothesis that
PCD in protozoa contributes to their density regulation.
Clear experimental evidence to support this hypothesis
has mostly been obtained in vitro whereas the situation
in vivo is more complex and may often be obscured by
the immune response of the host. Thus, while there is
evidence that parasite PCD can indeed regulate parasite
populations a main question that remains still unan-
swered is whether apoptosis in these parasites has
evolved as a mechanism to determine parasite densities.
Alternatively, apoptotic pathways in protozoan parasites
can also be favoured during evolution by contributing to
the evasion of the hosts’ immune response thereby
increasing parasite fitness.
Immune silencing by apoptotic protozoan parasites
For the immune silencing potential of apoptotic proto-
zoan parasites (Table 1) one has to take into account
which lifestyle the parasite prefers. Being an obligate
intracellular parasite preferring phagocytes as is the case
for Leishmania, being intracellular in a wide range of
host cells including phagocytic and non-phagocytic cells
as is the case for Toxoplasma or a restricted range of
non-phagocytic host cells as in the case of Plasmodium
and T. cruzi as well as being extracellular as is the case
for T. brucei.
Taking an obligate intracellular parasite preferring
phagocytes, immune silencing of these host cells is a
three step process [49]. This process is best described as
the silent uptake of apoptotic mammalian cells into pha-
gocytes [50-52]. First, apoptotic cells release “find-me”
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signals to recruit phagocytes to the site of apoptotic
death [53]. Second, phagocytes recognize the presence
of PS termed as “eat-me” signals on the membrane of
apoptotic cells [51,54]. The final step is an active sup-
pression of inflammation and immune response and can
be termed as a “forget me” signal. Since apoptotic cells
do not represent danger, their uptake does not result in
the activation of antimicrobial effector functions of pha-
gocytes [55,56]. This step is characterized by the release
of anti-inflammatory cytokines such as TGF-b and IL-10
and lipids like the eicosanoids 15-S-HETE and lipoxin-
A4 (LxA4). At the same time, pro-inflammatory cyto-
kines like TNF and lipids like leukotriene-B4 are down-
regulated [50,52,57]. LxA4 enhances uptake of apoptotic
cells and downregulates the production of IL-12 and the
development of a TH-1 response [58].
Apoptotic Leishmania: An essential factor for successful
infection
Taking Leishmania as a prototypic obligate intracellular
parasite living inside phagocytes it has been demon-
strated that Leishmania targets this three step process
in at least two phases of establishing intracellular survi-
val [49]. First L. major promastigotes produce a “find
me” signal termed Leishmania chemotactic factor (LCF)
recruiting its first host cell, i.e. the neutrophil (PMN)
[59]. Moreover, it was shown that successful PMN inva-
sion depends on the expression of the “eat me” signal
PS on a sub-population of apoptotic parasites. After
depleting the apoptotic parasites from a virulent popula-
tion, L. major do not survive in phagocytes in vitro and
lose their disease inducing ability in vivo [60,61]. It was
also shown that promastigote survival depends on the
PMN production of a “forget me” signal. PMN interac-
tion with PS-positive promastigotes induce the produc-
tion of TGF-b downregulating inflammatory TNF.
Moreover, interaction with viable promastigotes alone
induces a TNF dependent killing of intracellular pro-
mastigotes [60]. In the second phase of infection, Leish-
mania promastigotes infect macrophages and
differentiate into the disease propagating multiplying
amastigote form. Being first inside PMN these promasti-
gote-infected cells start producing a “find me” signal in
the form of MIP-1b specifically recruiting macrophages.
At the same time infected PMN gradually becomes
apoptotic and PS-positive. L. major can now use PMN
as a ‘Trojan horse’ for a successful silent entry into
macrophages [62,63]. As in the first phase of PMN
infection this ‘Trojan horse’ strategy is mediated via the
PS “eat me” signal on apoptotic PMN and “forget me”
signals in the form of TGF-b produced by macrophages
[62]. In vivo imaging has contributed a second evasion
mechanism, recently termed ‘Trojan rabbit’ strategy,
where parasites escape dying neutrophils to infect
macrophages [63,64]. Disease propagation is mediated
by amastigotes that were suggested to use PS expression
as a form of apoptotic mimicry [65]. Here it was
demonstrated that mouse-derived amastigotes are PS-
positive and viable and that the presence of PS mediates
a TGF-b dependent virulence of the amastigotes [65].
Immune silencing and trypanosomes
When analyzing the expression of PS on T. cruzi it was
found that the apoptotic “eat me” signal was only pre-
sent on the infective trypomastigotes (TRY), but not on
the epimastigotes or intracellular amastigotes. In addi-
tion, it was demonstrated that the infective trypomasti-
gotes uses a PS-dependent induction of TGF-b, thereby
downregulating anti-parasitic activity of iNOS, enabling
survival inside macrophages [66]. Moreover, T. cruzi has
evolved a second evasion strategy based on the anti-
inflammatory effect of TGF-b. In an experimental model
for Chagas’ disease it was found that the parasites
induce an intense lymphocyte apoptosis [67]. Subse-
quently, this group demonstrated that the interaction of
apoptotic but not necrotic lymphoyctes drives parasite
growth in a TGF-b dependent manner [68]. Inhibiting
the anti-inflammatory properties of TGF-b using
cyclooxygenase inhibitors abolishes the pro-parasitic
effect of apoptotic cell-macrophage interaction [68]. In a
similar fashion injection of apoptotic neutrophils prior
to Leishmania infection boost the parasitic growth [69].
As discussed above, T. brucei initiate cell death in the
SS form which do not replicate and is unable to re-dif-
ferentiate into replicating LS. The reason for this at first
seemed unclear but it has been speculated that it consti-
tutes a second control point after terminal differentia-
tion [20]. Here, we speculate that it may rather
represent a means to modulate the host’s immune
response to the parasite, since a continuously high num-
ber of stumpy parasites may favour an overwhelming
inflammatory response with detrimental effects for both
the parasite and the host. Apoptotic T. brucei gambiense
have indeed been shown to dampen the inflammatory
response of human macrophages [70].
Immune silencing and Toxoplasma
Inducible nitric oxide synthase (iNOS) regulation of
nitric oxide (NO) also controls T. gondii growth. PS-
expression on T. gondii was shown to induce TGF-b
production by macrophages. The PS-binding protein
Annexin-A5 reactivates the NO production and leads to
the killing of T. gondii [71]. Therefore, an autocrine
effect of TGF-b results in iNOS degradation, actin fila-
ment (F-actin) depolymerization and lack of nuclear fac-
tor-B (NF-B) in the nucleus contributing to PS-
dependent T. gondii survival [71]. All these features can
be reverted by TGF-b neutralizing antibody treatment.
Recently, another mechanism involving PCD in the
form of autophagy was shown to enhance intracellular
T. gondii proliferation. T. gondii infection of both HeLa
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cells and primary fibroblasts induces host cell autop-
hagy, dependent on ATG5 but independent of host
mTOR signaling. Subsequently, this pathogen exploits
the nutritive function of host autophagy to enhance its
intracellular growth [72].
Immune silencing and Plasmodium
In contrast to the protozoan parasites mentioned above,
for Plasmodium different hallmarks of apoptotic cell
death have been recognized [35,73], but an immune
silencing function has not yet been described. Since
Plasmodium parasite stages do not need to immunologi-
cally silence phagocytes for a productive infection, it is
not yet clear how PS-expression detected on different
parasite stages can contribute in the parasites pathogen-
esis. Interestingly, the liver stage of the parasite hides
inside a PS-negative bleb derived of hepatocytes to
silently spread the parasites back into the blood circula-
tion system [74].
Autophagy, recycling of organelles, and parasite
differentiation
Protozoan parasites possess complex life cycles and are
regularly transmitted between completely different host
species. The diverse environments of different hosts but
also different life styles of the same parasite species
within a given host require extensive parasite adapta-
tions and differentiation. During recent years, autophagy
in protozoa has emerged as crucial mechanisms during
these processes (Table 1). Whether autophagy during
parasite differentiation can also culminate in autophagic
cell death, however, is still unclear.
Differentiation in Leishmania parasites
Database searches have identified homologues of autop-
hagy related genes (ATG) in Leishmania parasites
[75-77]. The coordinated action of ATG products regu-
lates formation of autophagosomes, i.e. those organelles
that contain the cellular cargo to be digested (see
above). In both mammals and yeast, autophagosomes
are formed by two different pathways: one involves
ATG8, the other ATG12 and ATG5. Upstream of the
autophagosome formation, TOR (target of rapamycin)
kinases control cell growth in higher eukaryotes in
response to nutrients, energy conditions, and growth
factors, initiating or not autophagy. In L. major, all ATG
proteins of the two ubiquitination cascades are present
(reviewed by [12]). Functional complementation in S.
cerevisiae ATG mutants demonstrated that homologues
of ATG5, ATG8, ATG10 and ATG12 could replace
their yeast counterparts [12].
It has been demonstrated that autophagy mediates dif-
ferentiation in L. major and L. mexicana [75,76]. Based
on GFP-labeled ATG8 that specifically label autophago-
somes in S. cerevisiae it was demonstrated that an
increase in the abundance of autophagosomes play a
role in L. mexicana differentiation of procyclic promasti-
gotes into metacyclics and their subsequent differentia-
tion to disease propagating AMA [76]. In addition, it
was demonstrated that cysteine peptidases CPA and
CPB are essential in this process and can be blocked by
the compound K11777 [76]. In mutant parasites without
CPA and CPB, promastigotes have an enhanced number
of autophagosome-containing lysosomes. Although these
mutated parasites survived, stage differentiation into
AMA was almost completely blocked. Moreover, it was
demonstrated that by inactivation of the L. major VPS4
gene, late stage endosomal sorting was blocked resulting
in an accumulation of cytosolic autophagosomes that
could not be processed further. As a result, Lm-vps4
mutants were less able to survive under autophagy indu-
cing conditions such as nutrient deprivation and these
parasites were unable to differentiate into metacyclic
promastigotes [75]. It has not yet been described
whether autophagy in Leishmania can also result in PS-
positivity and death.
Organelle recycling and differentiation in T. brucei sp
As other protozoan parasites, T. brucei has to adapt to
completely different environments in different hosts. In
mammals, LS parasites are adapted to the rich glucose
environment of the blood [78], and they undergo rapid
multiplication. Their energy metabolism depends exclu-
sively on glycolysis, which takes place within glycosomes
[79]. In contrast, SS parasites that accumulate at the
peaks of parasitaemia do not divide, and activate at least
some of the components required for fully active mito-
chondria as preadaptation to proline as the major energy
source in the tsetse. After uptake with the tsetse blood
meal, they complete the biochemical and morphological
changes that culminate in the generation of a prolifera-
tive procyclic cell population in the vector midgut. Pre-
vious work shows that the metabolism and enzymatic
contents of glycosomes but also their morphology and
intracellular localization in BSF and procyclic forms dif-
fer considerably [80]. These studies revealed that old
glycosomes were associated with lysosomes implicating
microautophagy, and were finally completely disinte-
grated while new ones were built, resulting in a gradual
shift [81]. Trypanosomes thus seem to have the machin-
ery to specifically degrade glycosomes and probably
mitochondria in a process called “glycophagy” [82].
These results confirm a role of autophagy in the differ-
entiation and environmental adaptation of African
trypanosomes.
Involvement of autophagy in T. cruzi differentiation
The most important triggers of differentiation of T.
cruzi are high cell density and nutritional stress [83].
Cell density and nutritional stress are interconnected
when the parasites reach stationary phase of growth in
axenic cultures. Under these conditions, EPI undergo
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apoptosis (see above), although autophagy could be con-
tributing to the increase in mortality during prolongued
cultivation [47]. However, under conditions of serum
deprivation, cytoplasmic vacuoles decorated with high
concentrations of the ubiquitin-like ATG8.1, a charac-
teristic feature of autophagy [47], can be observed.
Mutation of the glycine residue at the C terminus of
ATG8.1 abolishes accumulation, thus indicating proces-
sing by the cysteine peptidase ATG4 as observed in
higher eukaryotes [84]. In T. cruzi, starvation of EPI
occurs naturally in the gut of the insect vector, which is
known to suffer long periods of lack of food (up to 12
months) [85]. Thus, autophagy could represent a crucial
survival mechanism of T. cruzi in the gut of the insect
vector.
During transformation of proliferating non-infective
EPI into G0/G1-arrested metacyclic TRY (metacyclogen-
esis), EPI but not metacyclic TRY parasites massively
die by a process resembling apoptosis (see above). This
process also requires fast and extensive protein degrada-
tion and recycling of building blocks for the synthesis of
new macromolecules. Recent results have shown an
intense expression of ATG8.1 in differentiating EPI, sug-
gesting that these cells are undergoing autophagy. In
contrast, almost no ATG8.1 was expressed in normal
EPI or in fully developed metacyclic TRY which suggests
that autophagy is a very dynamic process [84].
Morphological and ultrastructural studies have shown
that the main organelle that is transformed during meta-
cyclogenesis are the reservosomes, the large endosomal
compartments in EPI where proteins and lipids are
accumulating [86]. Furthermore, reservosomes are
absent in cell culture-derived AMA and TRY [86]. The
reservosomal content is consumed during differentiation
to metacyclics, when they shrink and finally disappear.
Serine carboxypeptidase, i.e. a marker of reservosomes
and ATG8.1 partially colocalize in the reservosomes
during differentiation, a fact that is likely due to the
delivery of the autophagosome content to the reservo-
somes/lysosomes [84]. These data strongly suggest that
proteins accumulated in reservosomes are utilized by
the EPI forms as energy source during differentiation
and that autophagy may be crucial for their disappear-
ance in the vertebrate stages.
Autophagy and autophagic cell death as a response to
stress
During their transmission between different host species
or changes of their life style within a given host, para-
sites do not only undergo differentiation processes but
they also encounter cellular stress, e.g. temperature
shifts, starvation, or anti-parasitic effector mechanisms
(Table 1). Autophagy has been recognized during envir-
onmental adaptations of several protozoan parasites
which may facilitate parasite survival under certain
stress conditions. As in higher eukaryotes, however,
there is also in protozoan parasites a duality between
pro-survival and death-promoting roles of autophagy. In
addition, autophagic cell death in parasites has also been
described under stress conditions although its function
for the biology of the respective parasites remains
elusive.
Stress adaptation in T. brucei sp
Starvation is a physiological condition that trypano-
somes have to face within the insect gut. It has been
shown that limited amount of nutrients can be trans-
duced by the serine/threonine kinase TOR which is
then inhibited, inducing autophagy. Starvation of T. bru-
cei in vitro, by growing parasites in nutrient-limited
medium or rapamycin, a macrolide isolated from Strep-
tomyces hygroscopicus that binds to TOR, induce the
formation of autophagic organelles [87]. It is question-
able, however, if rapamycin induces autophagy in T.
brucei, because it does not disrupt the active TOR com-
plex as observed in higher eukaryotes [88].
ROS are common mediators of PCD which are
increased after nutritional stress and after treatment
with stress-inducing drugs [89]. In BSF trypanosomes,
ROS are produced during prostaglandin-induced apop-
tosis (see above) although when it reaches higher con-
centrations can induce necrosis [25]. Remarkably,
during these processes, autophagic structures can be
seen in parasites that try to eliminate damaged struc-
tures and survive [87]. Likewise, dihydroxyacetone
(DHA) that is used as a carbon source at low concentra-
tions can lead to a cell cycle arrest in the G2-phase and
formation of autophagic and multilamellar structures at
higher concentrations [15,90]. This process is accompa-
nied by cell membrane permeability, formation of ROS,
PS exposure and cell death [15,90].
Neuropeptides have been recently identified in mam-
mals after T. brucei infection. These peptides are tar-
geted to the parasite glycosome and induce autophagic
cell death in BSFs but not procyclic forms [16]. Neuro-
peptide-mediated autophagic cell death in T. brucei is
preceeded by an energy metabolism failure and can
thus be considered as being stress-related. Although
the effect of neuropeptides against LS or SS has to be
determined, this is an example of density control that
could also contribute to parasite differentiation (Figure
1; see also above). Differences between structure and
abundance of glycosylphosphatidylinositol (GPIs), gly-
cosylation patterns of surface proteins of BSFs and
procyclic forms, different endocytosis rates, carbohy-
drate metabolism, and glycosome dependency pre-
sented by each stage may be involved in the
differential susceptibility of different life-cycle stages to
these molecules.
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Autophagy in the stress response of T. cruzi
Treatment of T. cruci with lysophospholipid analogues
such as edelfosine or miltefosine leads to cytosolic
membrane arrangements, mitochondrial swelling and
appearance of concentric structures in EPI, i.e. the
insect stage, resembling autophagosome-like structures
[17]. Naphthoquinones derived from plants lead to signs
of an apoptosis-like process but formation of atypical
membrane structures in EPI and trypomastigotes (TRY)
suggests also the involvement of autophagy [18]. Propo-
lis, a bee product with microbicidal properties causes
mitochondrial swelling in EPI, with new membrane
structures inside this organelle and, in the cytosol,
altered vacuoles, formation of myelinated structures, and
reservosome disorganization [91]. This suggests a possi-
ble interference with lipid content and biosynthesis, and
in macromolecules accumulation [92]. Using terpenic
alcohols such as geranylgeraniol, endoplasmic reticulum
disorganization, myelin-like structures and concentric
membrane arrangements inside damaged mitochondria
were observed in all stages of T. cruzi, suggesting autop-
hagic events [93]. The ultrastructure of the parasites
after treatment with these chemotherapeutic agents sug-
gests autophagic cell death as a common phenotype
although signs of necrosis and apoptosis were also
observed [6]. This suggests the interplay of distinct
death mechanisms through a cross-talking of signalling
pathways as reported for mammalian cells (Figure 1)
[94]. Recently, the molecular features of autophagy in T.
cruzi have been characterized [84]. A bioinformatic ana-
lysis of the T. cruzi genome confirms the existence of all
major genes of the ATG8 conjugation system (ATG3,
ATG4, ATG7, ATG8), whereas the major components
of the ATG12-ATG5 conjugation system (ATG12,
ATG5, ATG10) are apparently lacking [95]. The
reduced set of genes involved in regulation and signal-
ling pathways of autophagy in trypanosomes as com-
pared to other eukaryotes might reflect the early
appearance of this process in evolution [96]. The two T.
cruzi autophagins (ATG4 proteases) are expressed con-
stitutively throughout the parasite life cycle and process
two recombinant ATG8 homologues at the Gly residue
[84]. Moreover, all the T. cruzi ATG4, and to a lesser
extent ATG8 homologues substitute their yeast counter-
parts in functional assays [84]. These results show that
ATG8 conjugation system in T. cruzi is highly similar to
the mammalian one, suggesting evolutionary conserva-
tion of this autophagic pathway.
Conclusions
Over the past 10-15 years considerable progress has
been made in the understanding how distinct PCD path-
ways in protozoan parasites may affect the biology of
protozoan parasites and their interactions with mamma-
lian hosts and invertebrate vectors (Figure 1). The
appearance of parasites displaying markers of apoptosis
or autophagy during distinct processes of parasite biol-
ogy as well as functional evidences has fuelled the view
that these PCD pathways play critical roles in the life
style of parasitic protozoa. In contrast, the impact of
parasite necrosis for parasite-host interactions and
whether it can occur in a regulated fashion as described
in metazoans [10,11] is completely unknown. There is
now good evidence that densities of distinct trypanoso-
matids and apicomplexan parasites can correlate with
the appearance of PCD markers indicative of apoptosis.
It has to be stressed, however, that a definite proof for
the concept of parasite density regulation by parasite
apoptosis is still missing, especially in vivo. This will
probably require the availability of mutant parasites that
are deficient in distinct regulators or executors of apop-
totic cell death indicating also the urgent need to char-
acterize underlying molecular mechanisms of PCD in
protozoan parasites. There are also clear indications that
apoptotic parasites with PS present in the outer leaflet
of their plasma membrane modulate host immunity by
limiting the inflammatory response of the host. This can













Figure 1 Possible impact of protozoan PCD pathways in
parasite biology and life-or-death decisions. Parasitism depends
on check points that control the population of the parasites and
the survival of the host. In this sense, the existence of different PCD
mechanisms in protozoan parasites appears to be crucial and may
regulate distinct biological processes that are decisive for the
outcome of infection. From a physiological point of view, PCD
pathways can determine cell densities and differentiation at least
under certain conditions, both processes being inter-connected by
the regulated cross-talk between apoptotic and autophagic
pathways. On the other hand, the involvement of autophagy on
organelle remodelling allows the parasites to accomplish their
complex life cycles and to adapt to different environments.
Regarding the parasite-host interaction, several parasites are able to
dampen immune responses and colonize the different
environments in the hosts using apoptotic signalling. Deregulation
of these processes can lead to activation of a predominant death
signalling pathway that might be used as an attractive therapeutic
strategy.
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parasites ‘misuse’ a pathway for the immunologically
silent removal of PS-exposing cells of their mammalian
hosts. Another common theme emerging from the
examples discussed above is that autophagy is involved
in the differentiation of protozoan parasites. In addition,
autophagy and autophagic cell death appear to be com-
mon responses when parasites encounter environmental
stress. Since differentiation often coincides with environ-
mental stress, for example during transmission from
mammalian hosts to vectors or vice versa the contribu-
tion of autophagy and/or autophagic cell death in these
processes may not be clearly distinguishable in each
case. Nevertheless, is has become clear that autophagy
in protozoan parasites - as in metazoan - primarily pro-
motes survival but can proceed to a programmed form
of death if adverse conditions within a hostile environ-
ment exceed cellular capacity. Although we are certainly
far away from a clear understanding, apoptosis and
autophagy thus appear to play important roles in proto-
zoan parasites and the interactions with their mamma-
lian hosts and invertebrate vectors. A detailed
knowledge of the underlying molecular mechanism
might open the possibility to combat protozoan para-
sites efficiently by promoting their own death pathways.
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